Radix puerariae and agkistrodon acutus venom wine and preparation method thereof
Through PBS dissolution and high-speed centrifugation, gel chromatography purification and sorghum wine neutralization technology, the pathogenic factors and toxic proteins in snake venom were removed, and the problem of the inability to confirm the safety of snake venom wine in the existing technology was solved, and safe and non-toxic were prepared. The venomous wine of Pueraria root ensures the safety and effectiveness of the product.
Patent Information
- Application Number
- CN202411123718.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-15
- Publication Date
- 2024-11-22
AI Technical Summary
The existing preparation methods for snake venom wine have not been able to fully purify snake venom wine and remove pathogenic bacteria, viruses and other pathogenic factors, resulting in the inability to scientifically confirm the safety of the product, hindering the promotion and use of snake venom wine.
PBS dissolution and high-speed centrifugation methods were used to remove pathogenic factors that were insoluble in water, and the small molecular weight virus components were purified by gel chromatography. Combined with the active ingredients in sorghum wine, the safe and non-toxic Pueraria stinger viper was prepared. Snake poison wine.
It effectively removes pathogenic factors and toxic proteins in snake venom, reduces the bleeding, edema, muscle and liver and kidney toxicity of snake venom wine, ensures the edible safety of the product, and solves the lack of safety evaluation of snake venom wine on the market.
Smart Images

Figure CN118987072A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of safe processing technology of traditional Chinese medicine, and in particular to safe and non-toxic pueraria snake venom wine and a preparation method thereof. Background Art
[0002] The venom of the Agkistrodon acutus is the secretion of the venom glands on both sides of the jaw of the Agkistrodon acutus. It is a milky white or slightly yellow viscous liquid with a unique fishy smell and a slightly sour taste. The venom of the Agkistrodon acutus has significant pharmacological effects such as anti-cardiovascular disease, anti-thrombosis, anti-tumor, analgesia, anti-inflammatory and antibacterial, especially in anti-inflammatory, analgesia, procoagulant, anticoagulant, antithrombotic, anti-tumor, antibacterial and antiviral. However, the toxic components of the venom of the Agkistrodon acutus are complex, mainly blood circulation toxins, containing complexes composed of polypeptides and multiple enzymes, phospholipase A2, proteases and kallikreins, etc.; secondly, fresh snake venom venom may carry pathogenic bacteria, viruses, mycoplasmas and other pathogenic pathogens, which are not good for human health. Therefore, improper handling of the venom products of the Agkistrodon acutus will cause severe tissue bleeding, edema, muscle degradation and liver and kidney toxicity to human or animal tissues, and the market lacks a systematic and effective evaluation standard, which poses a health threat and also hinders the research and development and listing of snake venom wine.
[0003] Pueraria thomsonii Benth is a "substance that is both a food and a Chinese medicinal material" approved by the National Health Commission, which is a plant with medicinal and edible properties. It has the effects of promoting the production of body fluids and quenching thirst, promoting blood circulation and activating collaterals. The active ingredients of Pueraria thomsonii Benth mainly include isoflavones, pueraria glycosides, alkaloids, etc. Among them, isoflavone compounds such as puerarin, daidzein, daidzein, and biochanin A are the main medicinal active ingredients in Pueraria thomsonii Benth. Modern pharmacological studies have shown that Pueraria thomsonii Benth has multiple pharmacological effects such as maintaining the stability of the cardiovascular system, protecting brain nerves, anti-oxidation, reducing "three highs", treating liver and kidney damage, sobering up and protecting the liver, improving metabolism and enhancing immunity.
[0004] The prior art discloses the formula and preparation method of some snake venom wines, as well as their effects in clearing blood clots, fighting cancer, treating cardiovascular diseases, rheumatism, and rheumatoid arthritis. The patent "A formula and preparation method of five-step snake venom wine for clearing blood clots and enhancing cell vitality" (CN202110925035.6) only involves a formula and preparation method of five-step snake venom wine for clearing blood clots and enhancing cell vitality; the patent "Anti-cancer snakeberry wine and preparation method thereof" (CN201510359419.0) only involves an anti-cancer snakeberry wine and a preparation method thereof; the patent "Agkistrodon acutus venom wine and preparation method thereof" (CN201010283762.9); the patent "A snake venom wine for treating cardiovascular diseases and preparation method thereof" (CN200910144238.0) only involves a snake venom wine for treating cardiovascular diseases and a preparation method thereof; the patent "A snake venom product for treating rheumatism and rheumatoid arthritis" (CN01102835.1) only involves a snake venom product for treating rheumatism and rheumatoid arthritis. The above technologies all have the following problems: ① The snake venom is not fully purified to prepare it, and the interference of pathogenic pathogens such as pathogenic bacteria, viruses, mycoplasma, etc. on human health is not removed; ② A systematic safety evaluation of snake venom products is not conducted, and the acute and chronic toxicity to humans cannot be scientifically confirmed, which is not conducive to the promotion and use of the products. Summary of the invention
[0005] The purpose of the invention is to develop a safe and non-toxic Pueraria acutus venom wine and a preparation process thereof.
[0006] To achieve the above purpose, the scheme provided by the present invention is as follows:
[0007] A kudzu root and agkistrodon acutus venom wine, characterized in that it comprises the following components: 0.2-0.3 g / L of kudzu root ethanol extract, 2-3 g / L of refined agkistrodon acutus venom, and the rest is 50-55° kaoliang liquor.
[0008] In some embodiments, the purified Agkistrodon acutus venom is prepared by centrifugation and gel chromatography purification of Agkistrodon acutus venom.
[0009] Natural fresh agkistrodon acutus venom inevitably carries pathogenic microorganisms, viruses and other water-insoluble toxic factor components, while the active components of snake venom, such as thrombin and nerve growth factor, are water-soluble active protein components. Therefore, the method of PBS dissolution and high-speed centrifugation can effectively remove pathogenic microorganisms, viruses and other water-insoluble toxic factor components in fresh agkistrodon acutus venom, ensuring the safety of snake venom wine.
[0010] In addition, the natural fresh Agkistrodon acutus venom contains toxic proteins (≤20kDa) such as cytotoxins and hemorrhagic toxins, while the active components of snake venom such as thrombin and nerve growth factor are water-soluble active protein components with molecular weights between 25-100kDa. Therefore, gel chromatography can effectively remove large-diameter viral components and small-molecular-weight cytotoxins, hemorrhagic toxins and other toxic proteins (≤20kDa) to ensure the safety of snake venom wine.
[0011] The present application also provides a method for preparing the above-mentioned Agkistrodon acutus venom wine, comprising the following preparation steps:
[0012] Step 1: crude preparation of Agkistrodon acutus venom: fresh Agkistrodon acutus venom was dissolved in phosphate buffer solution (PBS, 0.1-0.2 mol / L) at pH 6.7-8.2, and centrifuged at 5000-6000 rpm / min for 10-12 min to remove the precipitate;
[0013] Step 2: Purification of Agkistrodon acutus venom, selecting agarose and dextran gel as fillers (particle size 20-40 μm), calculating the volume of fresh Agkistrodon acutus venom in step 1, loading the column with 20-25 times the volume of agarose and dextran gel, eluting with PBS (0.1-0.2 mol / L, pH 6.7-8.2), setting the elution temperature to 3-4° C., collecting 1 / 4 of the total elution volume as a fraction, collecting the third fraction as the target eluate, concentrating and freeze-drying to purify Agkistrodon acutus venom;
[0014] Step 3: Preparation of sorghum wine: add 2-3 g / L of refined Agkistrodon acutus venom and 0.2-0.3 g / L of Pueraria lobata ethanol extract to each liter of sorghum wine, and seal for 6-7 days for preparation.
[0015] In some embodiments, the ratio of the height H to the diameter D of the gel column should be 20≤H / D≤30. The physical properties of agarose and dextran gels are high resolution, high hardness, fast flow rate, stable chemical properties, low nonspecific adsorption, high recovery rate, easy to scale up, and good separation efficiency.
[0016] In some embodiments, the processing is a light-proof and room-temperature treatment. The natural fresh agkistrodon acutus venom contains toxic substances such as toxic proteins of the serine protease family, the metalloprotease family, and the phospholipase A2 protein family. Poisoning can cause serious tissue bleeding, edema, muscle degradation, and liver and kidney toxicity to human or animal tissues, posing a health threat and hindering the development and listing of snake venom wine. Sorghum wine contains a variety of esters, alcohols, aldehydes, ketones, and alkanes active ingredients rich in ethyl acetate, ethyl hexanoate, ethyl octanoate, 3-methylbutanol, furfural, nonanal, etc., which can more effectively neutralize and denature cytotoxins, hemorrhagic toxins, phospholipase A2, proteases, and kinins, and obtain safe edible agkistrodon acutus venom wine.
[0017] At the same time, the ethanol extract of Pueraria root is rich in isoflavone active ingredients such as puerarin, daidzein, daidzein, and biochanin, which have significant alcohol-resolving and liver-protecting activities; the isoflavone active ingredients can also effectively neutralize toxic substances such as denaturing cytotoxins, hemorrhagic toxins, phospholipase A2, proteases, and kinins, thereby obtaining a safe edible Agkistrodon acutus venom wine.
[0018] The present invention provides a Pueraria root Agkistrodon acutus venom wine and a preparation method thereof. The invention has the following beneficial effects: the invention can reduce the toxic components in Agkistrodon acutus venom through the action of various components, and prepare a safe and non-toxic Pueraria root snake venom wine. The invention removes toxic components such as toxic proteins of the serine protease family, metalloprotease family, and phospholipase A2 protein family that are toxic to the human body through the rough and refined treatment of Agkistrodon acutus venom. The Agkistrodon acutus venom wine prepared by sorghum wine does not have bleeding, edema, muscle, liver and kidney toxicity. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0020] Figure 1 It is the result of the hemorrhagic toxicity test of snake venom wine;
[0021] Figure 2 It is the result of the edema toxicity test of snake venom wine;
[0022] Figure 3 These are the results of the muscle toxicity experiment of snake venom wine. DETAILED DESCRIPTION
[0023] In order to make the purpose, technical scheme and advantages of the present invention more clear, the present invention is further described in detail below in conjunction with the examples. The equipment and reagents used in each embodiment and test example can be obtained from commercial sources unless otherwise specified. The specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention.
[0024] Based on the information contained in this application, it is easy for those skilled in the art to make various changes to the precise description of the present invention without departing from the spirit and scope of the appended claims. It should be understood that the scope of the present invention is not limited to the defined process, properties or components, because these embodiments and other descriptions are only for illustrating specific aspects of the present invention. In fact, various changes that the technicians in this field or related fields can obviously make to the embodiments of the present invention are all covered within the scope of the appended claims.
[0025] In order to better understand the present invention but not to limit the scope of the present invention, all the numbers used in this application to express the amount, percentage, and other numerical values should be understood as modified by the word "approximately" in all cases. Therefore, unless otherwise specified, the numerical parameters listed in the specification and the appended claims are approximate values, which may be changed according to the different ideal properties attempted to be obtained. Each numerical parameter should at least be regarded as obtained based on the reported significant figures and by conventional rounding methods. In the present invention, "about" means within 10% of a given value or range, preferably within 5%.
[0026] In the following embodiments of the present invention, when the temperature is not particularly limited, it is room temperature. Room temperature refers to the natural room temperature in four seasons without additional cooling or heating treatment, and is generally controlled at 10-30°C, preferably 15-25°C.
[0027] Unless otherwise specified, the reagents and materials used in the embodiments of the present invention can be purchased from the market.
[0028] Example 1
[0029] Crude preparation of Agkistrodon acutus venom: fresh Agkistrodon acutus venom was taken and dissolved in phosphate buffered saline (PBS, 0.15 mol / L) at pH 6.7, ultrasonicated at 4°C for 1.5 h, and centrifuged at 6000 rpm / min for 12 min to remove the precipitate.
[0030] Purification of Agkistrodon acutus venom: Gel chromatography purification and impurity removal, concentration of active ingredients: Select highly cross-linked agarose and dextran gel (particle size 20-40μm) as fillers, calculate the volume of fresh Agkistrodon acutus venom after centrifugation and impurity removal, and load 25 times the volume of agarose and dextran gel into the column. Column loading requirements: The ratio of the height H and diameter D of the gel column should be 20≤H / D≤30. Use PBS (0.15moL / L, pH 7.0) for elution, set the elution temperature to 4℃, collect 1 / 4 of the total elution volume as one component, and collect the third component as the target eluate (molecular weight 25-100kDa), concentrate and freeze-dry, and it is the purified safe and non-toxic active ingredient of snake venom.
[0031] Preparation of sorghum liquor, removal of toxic substances: add 50% Vol sorghum liquor at 3 / 1 (g / L, m / v).
[0032] Active ingredients of Pueraria root neutralize toxic substances: Pueraria root ethanol extract is added at a ratio of 1.5 / 5 (g / L, m / v), immersed and sealed for 7 days for processing to remove toxic substances, thereby obtaining Agkistrodon acutus venom wine that is safe to eat.
[0033] Example 2
[0034] Crude preparation of Agkistrodon acutus venom: fresh Agkistrodon acutus venom was taken and dissolved in phosphate buffered saline (PBS, 0.15 mol / L) at pH 7.0, ultrasonicated at 4°C for 1.5 h, and centrifuged at 6000 rpm / min for 12 min to remove the precipitate.
[0035] Purification of Agkistrodon acutus venom: Gel chromatography purification and impurity removal, concentration of active ingredients: Select highly cross-linked agarose and dextran gel (particle size 20-40μm) as fillers, calculate the volume of fresh Agkistrodon acutus venom after centrifugation and impurity removal, and load 25 times the volume of agarose and dextran gel into the column. Column loading requirements: The ratio of the height H and diameter D of the gel column should be 30. Use PBS (0.15moL / L, pH 7.0) for elution, set the elution temperature to 4℃, collect 1 / 4 of the total elution volume as one component, and collect the third component as the target eluate (molecular weight 25-100kDa), concentrate and freeze-dry, and it is the purified safe and non-toxic active ingredient of snake venom.
[0036] Preparation of sorghum liquor, removal of toxic substances: add 50% Vol sorghum liquor at 2 / 1 (g / L, m / v).
[0037] Active ingredients of Pueraria root neutralize toxic substances: 1 / 5 (g / L, m / v) of Pueraria root ethanol extract is added to the mixture and soaked and sealed for 6 days for processing to remove toxic substances, thereby obtaining Agkistrodon acutus venom wine that is safe to eat.
[0038] Example 3
[0039] Crude preparation of Agkistrodon acutus venom: fresh Agkistrodon acutus venom was taken and dissolved in phosphate buffered saline (PBS, 0.2 mol / L) at pH 7.5, ultrasonicated at 3°C for 1 h, and centrifuged at 5000 rpm / min for 10 min to remove the precipitate.
[0040] Purification of Agkistrodon acutus venom: Gel chromatography purification and impurity removal, concentration of active ingredients: Select highly cross-linked agarose and dextran gel (particle size 20-40μm) as fillers, calculate the volume of fresh Agkistrodon acutus venom after centrifugation and impurity removal, and load the column with 20 volumes of agarose and dextran gel. Column loading requirements: The ratio of the height H and diameter D of the gel column should be 25. Use PBS (0.2moL / L, pH7.5) for elution, set the elution temperature to 3℃, collect 1 / 4 of the total elution volume as one component, and collect the third component as the target eluate (molecular weight 25-100kDa), concentrate and freeze-dry, and it is a purified safe and non-toxic active ingredient of snake venom.
[0041] Preparation of sorghum liquor, removal of toxic substances: add 50% Vol sorghum liquor at 2 / 1 (g / L, m / v).
[0042] Active ingredients of Pueraria root neutralize toxic substances: 1 / 5 (g / L, m / v) of Pueraria root ethanol extract is added to the mixture and soaked and sealed for 6 to 7 days for processing to remove toxic substances, thereby obtaining Agkistrodon acutus venom wine that is safe to eat.
[0043] Comparative Example 1
[0044] Compared with Example 1, the crude preparation process of Agkistrodon acutus venom was eliminated, that is, PBS dissolution and high-speed centrifugation were not performed to remove impurities. The remaining steps were performed according to Example 1.
[0045] Comparative Example 2
[0046] Compared with Example 2, the purification operation of Agkistrodon acutus venom for concentrating the active ingredients by gel chromatography purification and impurity removal was subtracted, that is, gel chromatography purification and impurity removal were not performed, and the remaining steps were performed according to Example 2.
[0047] Comparative Example 3
[0048] Compared with Example 3, the active ingredient of Pueraria root was removed, and the remaining steps were carried out according to Example 3.
[0049] Toxicological experiments of snake venom wine:
[0050] Study on the hemorrhagic toxicity of Agkistrodon acutus venom wine
[0051] The snake venom wine of Example 1, Example 2, Example 3 and Control Example 1, Control Example 2, and Control Example 3 was prepared with physiological saline, and 0.1 ml was injected subcutaneously into the back skin of mice. The mice were killed 2 hours later, and the diameter of the bleeding point on the back skin was measured. The minimum hemorrhagic dose (MHD) was the dose that caused a bleeding point with a diameter of 10 mm 2 hours after injection.
[0052] The back skin of mice in each group injected subcutaneously with the snake venom wine of Example 1, Example 2, and Example 3 showed no obvious bleeding spots (such as Figure 1 A), while the snake venom of control example 1, control example 2, and control example 3 showed significant bleeding spots (such as Figure 1 B. 2cm long, 1.2cm wide).
[0053] Study on the edema toxicity of Agkistrodon acutus venom wine
[0054] The snake venom wine of Example 1, Example 2, Example 3 and Control Example 1, Control Example 2, and Control Example 3 was prepared with physiological saline, and 0.5 ml was injected subcutaneously into the right foot of the mouse, and an equal volume of physiological saline was injected subcutaneously into the left foot. The mice were killed 3 hours after the injection, and the weight of each foot was measured. Edema was quantified as the weight increase of the right limb relative to the left limb: edema amount = right limb weight - left limb weight.
[0055] like Figure 2The weight gain of the calf of mice in the groups treated with the Agkistrodon acutus venom wine obtained in Control Examples 1, 2, and 3 was compared with the weight gain of the calf of mice in the groups treated with the Agkistrodon acutus venom wine obtained in Examples 1, 2, and 3, and there was significant edema.
[0056] Study on the muscle toxicity of Agkistrodon acutus venom wine
[0057] The snake venom wine of Example 1, Example 2, Example 3 and Control Example 1, Control Example 2, and Control Example 3 was prepared with physiological saline, and 1 ml was subcutaneously injected into the right gastrocnemius muscle of mice. Blood was collected from the orbital plexus of mice 3 hours after injection, and serum was obtained by centrifugation at 4000 r / min for 10 minutes at 4°C, and the enzyme activity was determined according to the instructions of the creatine kinase (CK) assay kit.
[0058] like Figure 3 As shown, the creatine kinase of different example groups were 0.32±0.03U / ml, 0.33±0.01U / ml, 0.33±0.02U / ml (all within the normal level range of 0-0.4), while the creatine kinase of control example 1, control example 2, and control example 3 groups were 0.45±0.02U / ml, 0.48±0.02U / ml, 0.50±0.01U / ml, indicating that the Agkistrodon acutus snake venom wine without impurity removal operation still has muscle toxicity.
[0059] Study on the toxicity of Agkistrodon acutus venom wine on liver and kidney function
[0060] 60 healthy male Kunming mice were selected, and after 7 days of adaptive feeding, they were randomly divided into 6 groups, with 10 mice in each group: Example 1 Group, Example 2 Group, Example 3 Group and Control Group 1 Group, Control Group 2 Group, and Control Group 3. Snake venom wine with different treatments was gavaged with equal doses, and there was no restriction on feeding and water, which lasted for 14 days. One hour after the last administration of wine, blood was collected from the orbital plexus of the mice, and the collected blood samples were placed at 4°C for 4 hours. Serum was obtained by centrifugation at 750×g for 15 minutes, and urea (Urea), creatinine (CR), alanine aminotransferase, and aspartate aminotransferase were detected using a fully automatic biochemical analyzer, and the liver index and kidney index of the mice were recorded.
[0061] The body weight, kidney, and kidney / body weight of mice in the control group and the embodiment group are shown in Table 1. The renal function indicators urea and creatinine content of different embodiment groups were 6.04±0.83-6.34±0.97 μmol / L and 12.27±2.40-22.33±9.06 mmol / L, respectively, compared with the control group (6.65±0.67 μmol / L-10.54±1.35 μmol / L, 41.07±4.82 mmol / L-47.13±34.47 mmol / L), indicating that the Agkistrodon acutus snake venom wine of the embodiment group has no renal function toxicity, while the Agkistrodon acutus snake venom wine without impurity removal operation still has renal toxicity.
[0062] Table 1 Effects of snake venom wine on body weight and kidney of mice
[0063] Group Weight / g Kidney / g Kidney / weight Urea Creatinine Comparative Example 1 46.60±1.42 0.35±0.02 0.70±0.04 9.54±1.35 43.13±34.47 Comparative Example 2 49.22±1.59 0.33±0.01 0.75±0.07 <![CDATA[6.65±0.67 * ]]> 41.07±4.82 Comparative Example 3 48.22±1.53 0.34±0.03 0.74±0.07 10.54±1.35 47.13±34.47 Example 1 44.19±2.52 0.30±0.03 0.69±0.07 6.34±0.32 22.33±9.06 Example 2 47.61±3.03 0.32±0.01 0.71±0.08 6.34±0.97 12.27±2.40 Example 3 48.32±2.47 0.32±0.01 0.76±0.11 6.04±0.83 13.00±2.93
[0064] The body weight, liver, and liver / body weight of mice in the control group and the embodiment group are shown in Table 2. The liver function indexes of alanine aminotransferase and aspartate aminotransferase in different embodiment groups were 34.67±3.79~47.33±7.57U / L and 82.67±13.58~97.67±22.50U / L, respectively, compared with the control group (38.67±1.15U / L~51.00±10.00U / L, 187.33±2.89U / L~211.02±84.87U / L), indicating that the Agkistrodon acutus snake venom wine in the embodiment group has no liver function toxicity, while the Agkistrodon acutus snake venom wine without impurity removal operation has liver toxicity.
[0065] Table 2 Effects of snake venom wine on body weight and liver of mice
[0066] Group Weight / g Liver / g Liver / weight ALT Aspartate aminotransferase Comparative Example 1 46.60±1.42 2.15±0.09 4.62±0.25 48.00±10.00 200.00±84.87 Comparative Example 2 49.22±1.59 2.3±0.30 4.88±0.75 48.67±1.15 187.33±2.89 Comparative Example 3 48.60±1.54 2.28±0.08 4.76±0.65 51.00±10.00 211.02±84.87 Example 1 44.19±2.52 1.9±0.28 4.44±0.37 37.33±7.57 97.67±22.50 Example 2 47.61±3.03 2.1±0.18 4.45±0.22 34.67±3.79 82.67±13.58 Example 3 48.32±2.47 1.8±0.14 3.92±0.13 36.67±9.29 89.67±7.09
[0067] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A Pueraria root acutus agkistrodon venom wine, characterized in that: The composition includes the following ingredients: 0.2-0.3 g / L of kudzu root ethanol extract, 2-3 g / L of refined Agkistrodon acutus venom, and the rest is 50-55° kaoliang liquor.
2. The Pueraria root acutus venom wine according to claim 1, characterized in that: The refined Agkistrodon acutus venom is prepared by dissolving, centrifuging and purifying the Agkistrodon acutus venom through gel chromatography.
3. A method for preparing a Pueraria lobata acutus venom wine, characterized in that: The method comprises the following preparation steps: Step 1: crude preparation of Agkistrodon acutus venom: fresh Agkistrodon acutus venom is dissolved in a phosphate buffer solution with a pH of 6.7 to 8.2, and centrifuged at 5000 to 6000 rpm / min for 10 to 12 minutes to remove the precipitate; Step 2: Purification of Agkistrodon acutus venom, selecting agarose and dextran gel as fillers, calculating the volume of fresh Agkistrodon acutus venom in step 1, loading the column with 20 to 25 times the volume of agarose and dextran gel, eluting with PBS, setting the elution temperature at 3 to 4° C., collecting 1 / 4 of the total elution volume as a fraction, collecting the third fraction as the target eluate, concentrating and freeze-drying to purify Agkistrodon acutus venom; Step 3: Preparation of sorghum wine: add 2-3 g / L of refined Agkistrodon acutus venom and 0.2-0.3 g / L of Pueraria lobata ethanol extract to each liter of sorghum wine, and seal for 6-7 days for preparation.
4. The preparation method according to claim 3, characterized in that: After dissolving with phosphate buffer in step 1, ultrasonicate at 3-4°C for 1-2h.
5. The preparation method according to claim 3, characterized in that: The ratio of the height H to the diameter D of the gel column should be 20≤H / D≤30.
6. The preparation method according to claim 3, characterized in that: The processing is done at room temperature away from light.
